Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Corticosteroids Inhalation Formulation Market Insights, Forecast to 2030
Global Corticosteroids Inhalation Formulation Market Insights, Forecast to 2030
Industry: Medical Devices & Consumables
Published Date: 2024-09-11
Pages: 150 Pages
Report ld: 3318180
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Corticosteroids Inhalation Formulation Market Size(US$)
CAGR 2024-2030
7.2%
Market Size,2030
USD 30,520
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 20,110 million
Market Forecast in 2030(Value)
US$ 30,520 million
CAGR
7.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Corticosteroid inhalation formulations are a cornerstone in the long-term management of asthma and chronic obstructive pulmonary disease (COPD), aiming to control inflammation in the airways. These formulations deliver corticosteroids directly to the lungs, minimizing systemic absorption and reducing the risk of side effects compared to oral steroids. By reducing inflammation, corticosteroids help prevent asthma attacks and improve lung function. Inhalation devices like metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers are commonly used to administer these medications. Advances in inhaler technology have enhanced the precision and efficiency of drug delivery, improving patient adherence and overall disease control. Combination inhalers that pair corticosteroids with bronchodilators are also widely used, providing both anti-inflammatory and bronchodilatory effects in a single formulation.
The global Corticosteroids Inhalation Formulation market is projected to grow from US$ 20110 million in 2024 to US$ 30520 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period.
The US & Canada market for Corticosteroids Inhalation Formulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Corticosteroids Inhalation Formulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Corticosteroids Inhalation Formulation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Corticosteroids Inhalation Formulation include Recipharm AB, GSK, AstraZeneca, Novartis, Teva Respiratory, Boehringer Ingelheim International, Cipla, Merck, Lupin, Perrigo, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Corticosteroids Inhalation Formulation, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Corticosteroids Inhalation Formulation, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Corticosteroids Inhalation Formulation, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Corticosteroids Inhalation Formulation sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Corticosteroids Inhalation Formulation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Corticosteroids Inhalation Formulation sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Recipharm AB, GSK, AstraZeneca, Novartis, Teva Respiratory, Boehringer Ingelheim International, Cipla, Merck, Lupin, Perrigo, etc.
MARKET SEGMENTATION
By Company
- Recipharm AB
- GSK
- AstraZeneca
- Novartis
- Teva Respiratory
- Boehringer Ingelheim International
- Cipla
- Merck
- Lupin
- Perrigo
- Viatris
- Organon Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Fluticasone
- Budesonide
- Mometasone Furoate
- Beclomethasone
- Other
Segment by Application
- Hospitals
- Specialty Clinics
- Retail Pharmacy Chains
- Online Pharmacies
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Corticosteroids Inhalation Formulation in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Corticosteroids Inhalation Formulation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Corticosteroids Inhalation Formulation sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Corticosteroids Inhalation Formulation Product Introduction
1.2 Market by Type
1.2.1 Global Corticosteroids Inhalation Formulation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Fluticasone
1.2.3 Budesonide
1.2.4 Mometasone Furoate
1.2.5 Beclomethasone
1.2.6 Other
1.3 Market by Application
1.3.1 Global Corticosteroids Inhalation Formulation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Retail Pharmacy Chains
1.3.5 Online Pharmacies
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Corticosteroids Inhalation Formulation Revenue Estimates and Forecasts 2019-2030
2.2 Global Corticosteroids Inhalation Formulation Revenue by Region
2.2.1 Global Corticosteroids Inhalation Formulation Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Corticosteroids Inhalation Formulation Revenue by Region (2019-2024)
2.2.3 Global Corticosteroids Inhalation Formulation Revenue by Region (2025-2030)
2.2.4 Global Corticosteroids Inhalation Formulation Revenue Market Share by Region (2019-2030)
2.3 Global Corticosteroids Inhalation Formulation Sales Estimates and Forecasts 2019-2030
2.4 Global Corticosteroids Inhalation Formulation Sales by Region
2.4.1 Global Corticosteroids Inhalation Formulation Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Corticosteroids Inhalation Formulation Sales by Region (2019-2024)
2.4.3 Global Corticosteroids Inhalation Formulation Sales by Region (2025-2030)
2.4.4 Global Corticosteroids Inhalation Formulation Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Corticosteroids Inhalation Formulation Sales by Manufacturers
3.1.1 Global Corticosteroids Inhalation Formulation Sales by Manufacturers (2019-2024)
3.1.2 Global Corticosteroids Inhalation Formulation Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Corticosteroids Inhalation Formulation in 2023
3.2 Global Corticosteroids Inhalation Formulation Revenue by Manufacturers
3.2.1 Global Corticosteroids Inhalation Formulation Revenue by Manufacturers (2019-2024)
3.2.2 Global Corticosteroids Inhalation Formulation Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Corticosteroids Inhalation Formulation Revenue in 2023
3.3 Global Key Players of Corticosteroids Inhalation Formulation, Industry Ranking, 2021 VS 2022
3.4 Global Corticosteroids Inhalation Formulation Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Corticosteroids Inhalation Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Corticosteroids Inhalation Formulation, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Corticosteroids Inhalation Formulation, Product Offered and Application
3.8 Global Key Manufacturers of Corticosteroids Inhalation Formulation, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Corticosteroids Inhalation Formulation Sales by Type
4.1.1 Global Corticosteroids Inhalation Formulation Historical Sales by Type (2019-2024)
4.1.2 Global Corticosteroids Inhalation Formulation Forecasted Sales by Type (2025-2030)
4.1.3 Global Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
4.2 Global Corticosteroids Inhalation Formulation Revenue by Type
4.2.1 Global Corticosteroids Inhalation Formulation Historical Revenue by Type (2019-2024)
4.2.2 Global Corticosteroids Inhalation Formulation Forecasted Revenue by Type (2025-2030)
4.2.3 Global Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
4.3 Global Corticosteroids Inhalation Formulation Price by Type
4.3.1 Global Corticosteroids Inhalation Formulation Price by Type (2019-2024)
4.3.2 Global Corticosteroids Inhalation Formulation Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Corticosteroids Inhalation Formulation Sales by Application
5.1.1 Global Corticosteroids Inhalation Formulation Historical Sales by Application (2019-2024)
5.1.2 Global Corticosteroids Inhalation Formulation Forecasted Sales by Application (2025-2030)
5.1.3 Global Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
5.2 Global Corticosteroids Inhalation Formulation Revenue by Application
5.2.1 Global Corticosteroids Inhalation Formulation Historical Revenue by Application (2019-2024)
5.2.2 Global Corticosteroids Inhalation Formulation Forecasted Revenue by Application (2025-2030)
5.2.3 Global Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
5.3 Global Corticosteroids Inhalation Formulation Price by Application
5.3.1 Global Corticosteroids Inhalation Formulation Price by Application (2019-2024)
5.3.2 Global Corticosteroids Inhalation Formulation Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Corticosteroids Inhalation Formulation Market Size by Type
6.1.1 US & Canada Corticosteroids Inhalation Formulation Sales by Type (2019-2030)
6.1.2 US & Canada Corticosteroids Inhalation Formulation Revenue by Type (2019-2030)
6.2 US & Canada Corticosteroids Inhalation Formulation Market Size by Application
6.2.1 US & Canada Corticosteroids Inhalation Formulation Sales by Application (2019-2030)
6.2.2 US & Canada Corticosteroids Inhalation Formulation Revenue by Application (2019-2030)
6.3 US & Canada Corticosteroids Inhalation Formulation Market Size by Country
6.3.1 US & Canada Corticosteroids Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Corticosteroids Inhalation Formulation Revenue by Country (2019-2030)
6.3.3 US & Canada Corticosteroids Inhalation Formulation Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Corticosteroids Inhalation Formulation Market Size by Type
7.1.1 Europe Corticosteroids Inhalation Formulation Sales by Type (2019-2030)
7.1.2 Europe Corticosteroids Inhalation Formulation Revenue by Type (2019-2030)
7.2 Europe Corticosteroids Inhalation Formulation Market Size by Application
7.2.1 Europe Corticosteroids Inhalation Formulation Sales by Application (2019-2030)
7.2.2 Europe Corticosteroids Inhalation Formulation Revenue by Application (2019-2030)
7.3 Europe Corticosteroids Inhalation Formulation Market Size by Country
7.3.1 Europe Corticosteroids Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Corticosteroids Inhalation Formulation Revenue by Country (2019-2030)
7.3.3 Europe Corticosteroids Inhalation Formulation Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Corticosteroids Inhalation Formulation Market Size by Type
8.1.1 China Corticosteroids Inhalation Formulation Sales by Type (2019-2030)
8.1.2 China Corticosteroids Inhalation Formulation Revenue by Type (2019-2030)
8.2 China Corticosteroids Inhalation Formulation Market Size by Application
8.2.1 China Corticosteroids Inhalation Formulation Sales by Application (2019-2030)
8.2.2 China Corticosteroids Inhalation Formulation Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Corticosteroids Inhalation Formulation Market Size by Type
9.1.1 Asia Corticosteroids Inhalation Formulation Sales by Type (2019-2030)
9.1.2 Asia Corticosteroids Inhalation Formulation Revenue by Type (2019-2030)
9.2 Asia Corticosteroids Inhalation Formulation Market Size by Application
9.2.1 Asia Corticosteroids Inhalation Formulation Sales by Application (2019-2030)
9.2.2 Asia Corticosteroids Inhalation Formulation Revenue by Application (2019-2030)
9.3 Asia Corticosteroids Inhalation Formulation Market Size by Region
9.3.1 Asia Corticosteroids Inhalation Formulation Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Corticosteroids Inhalation Formulation Revenue by Region (2019-2030)
9.3.3 Asia Corticosteroids Inhalation Formulation Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Market Size by Type
10.1.1 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Market Size by Application
10.2.1 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Market Size by Country
10.3.1 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Overview
11.1.3 Recipharm AB Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Recipharm AB Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Recipharm AB Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GSK Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AstraZeneca Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Teva Respiratory
11.5.1 Teva Respiratory Company Information
11.5.2 Teva Respiratory Overview
11.5.3 Teva Respiratory Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Teva Respiratory Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Respiratory Recent Developments
11.6 Boehringer Ingelheim International
11.6.1 Boehringer Ingelheim International Company Information
11.6.2 Boehringer Ingelheim International Overview
11.6.3 Boehringer Ingelheim International Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Boehringer Ingelheim International Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim International Recent Developments
11.7 Cipla
11.7.1 Cipla Company Information
11.7.2 Cipla Overview
11.7.3 Cipla Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Cipla Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Recent Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Overview
11.8.3 Merck Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Merck Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 Lupin
11.9.1 Lupin Company Information
11.9.2 Lupin Overview
11.9.3 Lupin Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Lupin Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lupin Recent Developments
11.10 Perrigo
11.10.1 Perrigo Company Information
11.10.2 Perrigo Overview
11.10.3 Perrigo Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Perrigo Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Perrigo Recent Developments
11.11 Viatris
11.11.1 Viatris Company Information
11.11.2 Viatris Overview
11.11.3 Viatris Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Viatris Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Viatris Recent Developments
11.12 Organon Group
11.12.1 Organon Group Company Information
11.12.2 Organon Group Overview
11.12.3 Organon Group Corticosteroids Inhalation Formulation Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Organon Group Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Organon Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Corticosteroids Inhalation Formulation Industry Chain Analysis
12.2 Corticosteroids Inhalation Formulation Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Corticosteroids Inhalation Formulation Production Mode & Process
12.4 Corticosteroids Inhalation Formulation Sales and Marketing
12.4.1 Corticosteroids Inhalation Formulation Sales Channels
12.4.2 Corticosteroids Inhalation Formulation Distributors
12.5 Corticosteroids Inhalation Formulation Customers
13 Corticosteroids Inhalation Formulation Market Dynamics
13.1 Corticosteroids Inhalation Formulation Industry Trends
13.2 Corticosteroids Inhalation Formulation Market Drivers
13.3 Corticosteroids Inhalation Formulation Market Challenges
13.4 Corticosteroids Inhalation Formulation Market Restraints
14 Key Findings in the Global Corticosteroids Inhalation Formulation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Corticosteroids Inhalation Formulation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Fluticasone
Table 3. Major Manufacturers of Budesonide
Table 4. Major Manufacturers of Mometasone Furoate
Table 5. Major Manufacturers of Beclomethasone
Table 6. Major Manufacturers of Other
Table 7. Global Corticosteroids Inhalation Formulation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Corticosteroids Inhalation Formulation Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Corticosteroids Inhalation Formulation Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Corticosteroids Inhalation Formulation Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Corticosteroids Inhalation Formulation Revenue Market Share by Region (2019-2024)
Table 12. Global Corticosteroids Inhalation Formulation Revenue Market Share by Region (2025-2030)
Table 13. Global Corticosteroids Inhalation Formulation Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 14. Global Corticosteroids Inhalation Formulation Sales by Region (2019-2024) & (K Units)
Table 15. Global Corticosteroids Inhalation Formulation Sales by Region (2025-2030) & (K Units)
Table 16. Global Corticosteroids Inhalation Formulation Sales Market Share by Region (2019-2024)
Table 17. Global Corticosteroids Inhalation Formulation Sales Market Share by Region (2025-2030)
Table 18. Global Corticosteroids Inhalation Formulation Sales by Manufacturers (2019-2024) & (K Units)
Table 19. Global Corticosteroids Inhalation Formulation Sales Share by Manufacturers (2019-2024)
Table 20. Global Corticosteroids Inhalation Formulation Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Corticosteroids Inhalation Formulation Revenue Market Share by Manufacturers (2019-2024)
Table 22. Global Key Players of Corticosteroids Inhalation Formulation, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Corticosteroids Inhalation Formulation Price by Manufacturers (2019-2024) & (US$/Unit)
Table 24. Global Corticosteroids Inhalation Formulation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Corticosteroids Inhalation Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroids Inhalation Formulation as of 2023)
Table 26. Global Key Manufacturers of Corticosteroids Inhalation Formulation, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Corticosteroids Inhalation Formulation, Product Offered and Application
Table 28. Global Key Manufacturers of Corticosteroids Inhalation Formulation, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Corticosteroids Inhalation Formulation Sales by Type (2019-2024) & (K Units)
Table 31. Global Corticosteroids Inhalation Formulation Sales by Type (2025-2030) & (K Units)
Table 32. Global Corticosteroids Inhalation Formulation Sales Share by Type (2019-2024)
Table 33. Global Corticosteroids Inhalation Formulation Sales Share by Type (2025-2030)
Table 34. Global Corticosteroids Inhalation Formulation Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Corticosteroids Inhalation Formulation Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Corticosteroids Inhalation Formulation Revenue Share by Type (2019-2024)
Table 37. Global Corticosteroids Inhalation Formulation Revenue Share by Type (2025-2030)
Table 38. Corticosteroids Inhalation Formulation Price by Type (2019-2024) & (US$/Unit)
Table 39. Global Corticosteroids Inhalation Formulation Price Forecast by Type (2025-2030) & (US$/Unit)
Table 40. Global Corticosteroids Inhalation Formulation Sales by Application (2019-2024) & (K Units)
Table 41. Global Corticosteroids Inhalation Formulation Sales by Application (2025-2030) & (K Units)
Table 42. Global Corticosteroids Inhalation Formulation Sales Share by Application (2019-2024)
Table 43. Global Corticosteroids Inhalation Formulation Sales Share by Application (2025-2030)
Table 44. Global Corticosteroids Inhalation Formulation Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Corticosteroids Inhalation Formulation Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Corticosteroids Inhalation Formulation Revenue Share by Application (2019-2024)
Table 47. Global Corticosteroids Inhalation Formulation Revenue Share by Application (2025-2030)
Table 48. Corticosteroids Inhalation Formulation Price by Application (2019-2024) & (US$/Unit)
Table 49. Global Corticosteroids Inhalation Formulation Price Forecast by Application (2025-2030) & (US$/Unit)
Table 50. US & Canada Corticosteroids Inhalation Formulation Sales by Type (2019-2024) & (K Units)
Table 51. US & Canada Corticosteroids Inhalation Formulation Sales by Type (2025-2030) & (K Units)
Table 52. US & Canada Corticosteroids Inhalation Formulation Revenue by Type (2019-2024) & (US$ Million)
Table 53. US & Canada Corticosteroids Inhalation Formulation Revenue by Type (2025-2030) & (US$ Million)
Table 54. US & Canada Corticosteroids Inhalation Formulation Sales by Application (2019-2024) & (K Units)
Table 55. US & Canada Corticosteroids Inhalation Formulation Sales by Application (2025-2030) & (K Units)
Table 56. US & Canada Corticosteroids Inhalation Formulation Revenue by Application (2019-2024) & (US$ Million)
Table 57. US & Canada Corticosteroids Inhalation Formulation Revenue by Application (2025-2030) & (US$ Million)
Table 58. US & Canada Corticosteroids Inhalation Formulation Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. US & Canada Corticosteroids Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
Table 60. US & Canada Corticosteroids Inhalation Formulation Revenue by Country (2025-2030) & (US$ Million)
Table 61. US & Canada Corticosteroids Inhalation Formulation Sales by Country (2019-2024) & (K Units)
Table 62. US & Canada Corticosteroids Inhalation Formulation Sales by Country (2025-2030) & (K Units)
Table 63. Europe Corticosteroids Inhalation Formulation Sales by Type (2019-2024) & (K Units)
Table 64. Europe Corticosteroids Inhalation Formulation Sales by Type (2025-2030) & (K Units)
Table 65. Europe Corticosteroids Inhalation Formulation Revenue by Type (2019-2024) & (US$ Million)
Table 66. Europe Corticosteroids Inhalation Formulation Revenue by Type (2025-2030) & (US$ Million)
Table 67. Europe Corticosteroids Inhalation Formulation Sales by Application (2019-2024) & (K Units)
Table 68. Europe Corticosteroids Inhalation Formulation Sales by Application (2025-2030) & (K Units)
Table 69. Europe Corticosteroids Inhalation Formulation Revenue by Application (2019-2024) & (US$ Million)
Table 70. Europe Corticosteroids Inhalation Formulation Revenue by Application (2025-2030) & (US$ Million)
Table 71. Europe Corticosteroids Inhalation Formulation Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 72. Europe Corticosteroids Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Corticosteroids Inhalation Formulation Revenue by Country (2025-2030) & (US$ Million)
Table 74. Europe Corticosteroids Inhalation Formulation Sales by Country (2019-2024) & (K Units)
Table 75. Europe Corticosteroids Inhalation Formulation Sales by Country (2025-2030) & (K Units)
Table 76. China Corticosteroids Inhalation Formulation Sales by Type (2019-2024) & (K Units)
Table 77. China Corticosteroids Inhalation Formulation Sales by Type (2025-2030) & (K Units)
Table 78. China Corticosteroids Inhalation Formulation Revenue by Type (2019-2024) & (US$ Million)
Table 79. China Corticosteroids Inhalation Formulation Revenue by Type (2025-2030) & (US$ Million)
Table 80. China Corticosteroids Inhalation Formulation Sales by Application (2019-2024) & (K Units)
Table 81. China Corticosteroids Inhalation Formulation Sales by Application (2025-2030) & (K Units)
Table 82. China Corticosteroids Inhalation Formulation Revenue by Application (2019-2024) & (US$ Million)
Table 83. China Corticosteroids Inhalation Formulation Revenue by Application (2025-2030) & (US$ Million)
Table 84. Asia Corticosteroids Inhalation Formulation Sales by Type (2019-2024) & (K Units)
Table 85. Asia Corticosteroids Inhalation Formulation Sales by Type (2025-2030) & (K Units)
Table 86. Asia Corticosteroids Inhalation Formulation Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Corticosteroids Inhalation Formulation Revenue by Type (2025-2030) & (US$ Million)
Table 88. Asia Corticosteroids Inhalation Formulation Sales by Application (2019-2024) & (K Units)
Table 89. Asia Corticosteroids Inhalation Formulation Sales by Application (2025-2030) & (K Units)
Table 90. Asia Corticosteroids Inhalation Formulation Revenue by Application (2019-2024) & (US$ Million)
Table 91. Asia Corticosteroids Inhalation Formulation Revenue by Application (2025-2030) & (US$ Million)
Table 92. Asia Corticosteroids Inhalation Formulation Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 93. Asia Corticosteroids Inhalation Formulation Revenue by Region (2019-2024) & (US$ Million)
Table 94. Asia Corticosteroids Inhalation Formulation Revenue by Region (2025-2030) & (US$ Million)
Table 95. Asia Corticosteroids Inhalation Formulation Sales by Region (2019-2024) & (K Units)
Table 96. Asia Corticosteroids Inhalation Formulation Sales by Region (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Type (2019-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Type (2025-2030) & (K Units)
Table 99. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Type (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Type (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Application (2019-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Application (2025-2030) & (K Units)
Table 103. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Application (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Application (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 106. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue by Country (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Country (2019-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales by Country (2025-2030) & (K Units)
Table 110. Recipharm AB Company Information
Table 111. Recipharm AB Description and Major Businesses
Table 112. Recipharm AB Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Recipharm AB Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Recipharm AB Recent Developments
Table 115. GSK Company Information
Table 116. GSK Description and Major Businesses
Table 117. GSK Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. GSK Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GSK Recent Developments
Table 120. AstraZeneca Company Information
Table 121. AstraZeneca Description and Major Businesses
Table 122. AstraZeneca Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AstraZeneca Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. AstraZeneca Recent Developments
Table 125. Novartis Company Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Novartis Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Teva Respiratory Company Information
Table 131. Teva Respiratory Description and Major Businesses
Table 132. Teva Respiratory Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Teva Respiratory Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Teva Respiratory Recent Developments
Table 135. Boehringer Ingelheim International Company Information
Table 136. Boehringer Ingelheim International Description and Major Businesses
Table 137. Boehringer Ingelheim International Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Boehringer Ingelheim International Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Boehringer Ingelheim International Recent Developments
Table 140. Cipla Company Information
Table 141. Cipla Description and Major Businesses
Table 142. Cipla Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Cipla Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Cipla Recent Developments
Table 145. Merck Company Information
Table 146. Merck Description and Major Businesses
Table 147. Merck Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Merck Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merck Recent Developments
Table 150. Lupin Company Information
Table 151. Lupin Description and Major Businesses
Table 152. Lupin Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Lupin Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Lupin Recent Developments
Table 155. Perrigo Company Information
Table 156. Perrigo Description and Major Businesses
Table 157. Perrigo Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Perrigo Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Perrigo Recent Developments
Table 160. Viatris Company Information
Table 161. Viatris Description and Major Businesses
Table 162. Viatris Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Viatris Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Viatris Recent Developments
Table 165. Organon Group Company Information
Table 166. Organon Group Description and Major Businesses
Table 167. Organon Group Corticosteroids Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Organon Group Corticosteroids Inhalation Formulation Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Organon Group Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Corticosteroids Inhalation Formulation Distributors List
Table 173. Corticosteroids Inhalation Formulation Customers List
Table 174. Corticosteroids Inhalation Formulation Market Trends
Table 175. Corticosteroids Inhalation Formulation Market Drivers
Table 176. Corticosteroids Inhalation Formulation Market Challenges
Table 177. Corticosteroids Inhalation Formulation Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Corticosteroids Inhalation Formulation Product Picture
Figure 2. Global Corticosteroids Inhalation Formulation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Corticosteroids Inhalation Formulation Market Share by Type: 2023 & 2030
Figure 4. Fluticasone Product Picture
Figure 5. Budesonide Product Picture
Figure 6. Mometasone Furoate Product Picture
Figure 7. Beclomethasone Product Picture
Figure 8. Other Product Picture
Figure 9. Global Corticosteroids Inhalation Formulation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Corticosteroids Inhalation Formulation Market Share by Application: 2023 & 2030
Figure 11. Hospitals
Figure 12. Specialty Clinics
Figure 13. Retail Pharmacy Chains
Figure 14. Online Pharmacies
Figure 15. Other
Figure 16. Corticosteroids Inhalation Formulation Report Years Considered
Figure 17. Global Corticosteroids Inhalation Formulation Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 19. Global Corticosteroids Inhalation Formulation Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Corticosteroids Inhalation Formulation Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 21. Global Corticosteroids Inhalation Formulation Revenue Market Share by Region (2019-2030)
Figure 22. Global Corticosteroids Inhalation Formulation Sales (2019-2030) & (K Units)
Figure 23. Global Corticosteroids Inhalation Formulation Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 24. Global Corticosteroids Inhalation Formulation Sales Market Share by Region (2019-2030)
Figure 25. US & Canada Corticosteroids Inhalation Formulation Sales YoY (2019-2030) & (K Units)
Figure 26. US & Canada Corticosteroids Inhalation Formulation Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Europe Corticosteroids Inhalation Formulation Sales YoY (2019-2030) & (K Units)
Figure 28. Europe Corticosteroids Inhalation Formulation Revenue YoY (2019-2030) & (US$ Million)
Figure 29. China Corticosteroids Inhalation Formulation Sales YoY (2019-2030) & (K Units)
Figure 30. China Corticosteroids Inhalation Formulation Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Asia (excluding China) Corticosteroids Inhalation Formulation Sales YoY (2019-2030) & (K Units)
Figure 32. Asia (excluding China) Corticosteroids Inhalation Formulation Revenue YoY (2019-2030) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales YoY (2019-2030) & (K Units)
Figure 34. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue YoY (2019-2030) & (US$ Million)
Figure 35. Global Corticosteroids Inhalation Formulation Sales Share by Manufacturers (2023)
Figure 36. The Corticosteroids Inhalation Formulation Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 37. Global Corticosteroids Inhalation Formulation Revenue Share by Manufacturers (2023)
Figure 38. The Top 5 and 10 Largest Manufacturers of Corticosteroids Inhalation Formulation in the World: Market Share by Corticosteroids Inhalation Formulation Revenue in 2023
Figure 39. Global Corticosteroids Inhalation Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 40. Global Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
Figure 41. Global Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
Figure 42. Global Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
Figure 43. Global Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
Figure 44. US & Canada Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
Figure 45. US & Canada Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
Figure 46. US & Canada Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
Figure 47. US & Canada Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
Figure 48. US & Canada Corticosteroids Inhalation Formulation Revenue Share by Country (2019-2030)
Figure 49. US & Canada Corticosteroids Inhalation Formulation Sales Share by Country (2019-2030)
Figure 50. US Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 51. Canada Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 52. Europe Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
Figure 53. Europe Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
Figure 54. Europe Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
Figure 55. Europe Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
Figure 56. Europe Corticosteroids Inhalation Formulation Revenue Share by Country (2019-2030)
Figure 57. Europe Corticosteroids Inhalation Formulation Sales Share by Country (2019-2030)
Figure 58. Germany Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 59. France Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 60. U.K. Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 61. Italy Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 62. Russia Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 63. China Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
Figure 64. China Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
Figure 65. China Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
Figure 66. China Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
Figure 67. Asia Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
Figure 68. Asia Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
Figure 69. Asia Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
Figure 70. Asia Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
Figure 71. Asia Corticosteroids Inhalation Formulation Revenue Share by Region (2019-2030)
Figure 72. Asia Corticosteroids Inhalation Formulation Sales Share by Region (2019-2030)
Figure 73. Japan Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 74. South Korea Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 75. China Taiwan Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 77. India Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 78. Australia Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales Market Share by Type (2019-2030)
Figure 80. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue Market Share by Type (2019-2030)
Figure 81. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales Market Share by Application (2019-2030)
Figure 82. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue Market Share by Application (2019-2030)
Figure 83. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Revenue Share by Country (2019-2030)
Figure 84. Middle East, Africa and Latin America Corticosteroids Inhalation Formulation Sales Share by Country (2019-2030)
Figure 85. Brazil Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 86. Mexico Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 87. Turkey Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 88. Israel Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 89. GCC Countries Corticosteroids Inhalation Formulation Revenue (2019-2030) & (US$ Million)
Figure 90. Corticosteroids Inhalation Formulation Value Chain
Figure 91. Corticosteroids Inhalation Formulation Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Corticosteroids Inhalation Formulation market?
The top companies in the global Corticosteroids Inhalation Formulation market are Recipharm AB、GSK、AstraZeneca.
What was the global market size of Corticosteroids Inhalation Formulation in 2024?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Corticosteroids Inhalation Formulation market size from 2024 to 2030?
What was the global market size of Corticosteroids Inhalation Formulation in 2030?
Related Reports
Global Corticosteroids Inhalation Formulation Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Corticosteroids Inhalation Formulation market is projected to grow from US$ 21410 million in 2025 to US$ 34600 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 170
USD 4900.00
(Single User License)
Global Corticosteroids Inhalation Formulation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Corticosteroids Inhalation Formulation market size was US$ 21410 million in 2025 and is forecast to reach a readjusted size of US$ 34600 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 100
USD 4250.00
(Single User License)
Corticosteroids Inhalation Formulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Corticosteroids Inhalation Formulation was estimated to be worth US$ 21410 million in 2025 and is projected to reach US$ 34600 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 112
USD 3950.00
(Single User License)
Global Corticosteroids Inhalation Formulation Market Research Report 2026
The global Corticosteroids Inhalation Formulation market was valued at US$ 21410 million in 2025 and is anticipated to reach US$ 34600 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 120
USD 2900.00
(Single User License)
Global Corticosteroids Inhalation Formulation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Corticosteroids Inhalation Formulation market is projected to grow from US$ 20110 million in 2024 to US$ 32500 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 167
USD 4900.00
(Single User License)
Global Corticosteroids Inhalation Formulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Corticosteroids Inhalation Formulation market size was US$ 20110 million in 2024 and is forecast to a readjusted size of US$ 32500 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 99
USD 4250.00
(Single User License)
Corticosteroids Inhalation Formulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Corticosteroids Inhalation Formulation was estimated to be worth US$ 20110 million in 2024 and is forecast to a readjusted size of US$ 32500 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 113
USD 3950.00
(Single User License)
Global Corticosteroids Inhalation Formulation Market Research Report 2025
The global market for Corticosteroids Inhalation Formulation was valued at US$ 20110 million in the year 2024 and is projected to reach a revised size of US$ 32500 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published Date: 2025-03-10
Pages: 95
USD 2900.00
(Single User License)
Global Corticosteroids Inhalation Formulation Market Research Report 2024
Corticosteroid inhalation formulations are a cornerstone in the long-term management of asthma and chronic obstructive pulmonary disease (COPD), aiming to control inflammation in the airways. These formulations deliver corticosteroids directly to the lungs, minimizing systemic absorption and reducing the risk of side effects compared to oral steroids. By reducing inflammation, corticosteroids help prevent asthma attacks and improve lung function. Inhalation devices like metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers are commonly used to administer these medications. Advances in inhaler technology have enhanced the precision and efficiency of drug delivery, improving patient adherence and overall disease control. Combination inhalers that pair corticosteroids with bronchodilators are also widely used, providing both anti-inflammatory and bronchodilatory effects in a single formulation.
Published Date: 2024-09-11
Pages: 92
USD 2900.00
(Single User License)
Global and United States Corticosteroids Inhalation Formulation Market Report & Forecast 2024-2030
Corticosteroid inhalation formulations are a cornerstone in the long-term management of asthma and chronic obstructive pulmonary disease (COPD), aiming to control inflammation in the airways. These formulations deliver corticosteroids directly to the lungs, minimizing systemic absorption and reducing the risk of side effects compared to oral steroids. By reducing inflammation, corticosteroids help prevent asthma attacks and improve lung function. Inhalation devices like metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers are commonly used to administer these medications. Advances in inhaler technology have enhanced the precision and efficiency of drug delivery, improving patient adherence and overall disease control. Combination inhalers that pair corticosteroids with bronchodilators are also widely used, providing both anti-inflammatory and bronchodilatory effects in a single formulation.
Published Date: 2024-09-11
Pages: 133
USD 4350.00
(Single User License)
Global Corticosteroids Inhalation Formulation Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Corticosteroids Inhalation Formulation market is projected to grow from US$ 21410 million in 2025 to US$ 34600 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 170
USD 4900.00 (Single User License)Global Corticosteroids Inhalation Formulation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Corticosteroids Inhalation Formulation market size was US$ 21410 million in 2025 and is forecast to reach a readjusted size of US$ 34600 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 100
USD 4250.00 (Single User License)Corticosteroids Inhalation Formulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Corticosteroids Inhalation Formulation was estimated to be worth US$ 21410 million in 2025 and is projected to reach US$ 34600 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 112
USD 3950.00 (Single User License)Global Corticosteroids Inhalation Formulation Market Research Report 2026
The global Corticosteroids Inhalation Formulation market was valued at US$ 21410 million in 2025 and is anticipated to reach US$ 34600 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 120
USD 2900.00 (Single User License)Global Corticosteroids Inhalation Formulation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Corticosteroids Inhalation Formulation market is projected to grow from US$ 20110 million in 2024 to US$ 32500 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 167
USD 4900.00 (Single User License)Global Corticosteroids Inhalation Formulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Corticosteroids Inhalation Formulation market size was US$ 20110 million in 2024 and is forecast to a readjusted size of US$ 32500 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 99
USD 4250.00 (Single User License)Corticosteroids Inhalation Formulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Corticosteroids Inhalation Formulation was estimated to be worth US$ 20110 million in 2024 and is forecast to a readjusted size of US$ 32500 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 113
USD 3950.00 (Single User License)Global Corticosteroids Inhalation Formulation Market Research Report 2025
The global market for Corticosteroids Inhalation Formulation was valued at US$ 20110 million in the year 2024 and is projected to reach a revised size of US$ 32500 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-03-10
Pages: 95
USD 2900.00 (Single User License)Global Corticosteroids Inhalation Formulation Market Research Report 2024
Corticosteroid inhalation formulations are a cornerstone in the long-term management of asthma and chronic obstructive pulmonary disease (COPD), aiming to control inflammation in the airways. These formulations deliver corticosteroids directly to the lungs, minimizing systemic absorption and reducing the risk of side effects compared to oral steroids. By reducing inflammation, corticosteroids help prevent asthma attacks and improve lung function. Inhalation devices like metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers are commonly used to administer these medications. Advances in inhaler technology have enhanced the precision and efficiency of drug delivery, improving patient adherence and overall disease control. Combination inhalers that pair corticosteroids with bronchodilators are also widely used, providing both anti-inflammatory and bronchodilatory effects in a single formulation.
Published: 2024-09-11
Pages: 92
USD 2900.00 (Single User License)Global and United States Corticosteroids Inhalation Formulation Market Report & Forecast 2024-2030
Corticosteroid inhalation formulations are a cornerstone in the long-term management of asthma and chronic obstructive pulmonary disease (COPD), aiming to control inflammation in the airways. These formulations deliver corticosteroids directly to the lungs, minimizing systemic absorption and reducing the risk of side effects compared to oral steroids. By reducing inflammation, corticosteroids help prevent asthma attacks and improve lung function. Inhalation devices like metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers are commonly used to administer these medications. Advances in inhaler technology have enhanced the precision and efficiency of drug delivery, improving patient adherence and overall disease control. Combination inhalers that pair corticosteroids with bronchodilators are also widely used, providing both anti-inflammatory and bronchodilatory effects in a single formulation.
Published: 2024-09-11
Pages: 133
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now